Rituximab reduces the number of peripheral blood B-cells in vitro mainly by effector cell-mediated mechanisms.

Voso, Maria Teresa

Rituximab reduces the number of peripheral blood B-cells in vitro mainly by effector cell-mediated mechanisms. [electronic resource] - Haematologica Sep 2002 - 918-25 p. digital

Publication Type: Journal Article

0390-6078


Antibodies, Monoclonal--pharmacology
Antibodies, Monoclonal, Murine-Derived
B-Lymphocytes--cytology
CD3 Complex--metabolism
CD56 Antigen--metabolism
Cell Count
Cell Division--drug effects
Cell Line, Tumor
Cells, Cultured
Humans
Leukemia, B-Cell--pathology
Lipopolysaccharide Receptors--metabolism
Rituximab